SUMMARY
The authors studied in a 12-week trial the intraocular pressure reducing action of a 2% carteolol hydrochloride solution compared to 0,5% timolol maleate, in 34 individuals affected with ocular hypertension or primary open-angle glaucoma.
Both drugs produced a significant and equivalent reduction of intraocular pressure.
The 2% carteolol hydrochloride solution and the 0,5% timolol maleate as well didn't show relevant local or cardiovascular side effects.